With an estimated 1.6 million people living with either Crohn’s disease or ulcerative colitis in the United States, there is increasing need to research safe and effective ways to manage debilitating symptoms that–pardon the expression–hit patients right in the gut. Crohn’s and ulcerative colitis are considered the two main types of inflammatory bowel disease (IBD), and they manifest differently … [Read more...]